Completing the Arc: Targeted Inhibition of RET in Medullary Thyroid Cancer

被引:16
|
作者
Houvras, Yariv [1 ,2 ]
机构
[1] Weill Cornell Med Coll, New York, NY USA
[2] New York Presbyterian Hosp, New York, NY USA
关键词
MUTATIONS; CARCINOMAS; VANDETANIB; GENETICS; DISEASE; ZD6474;
D O I
10.1200/JCO.2011.38.7639
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:200 / 202
页数:3
相关论文
共 50 条
  • [41] Progression of Medullary Thyroid Cancer in RET Carriers of ATA Class A and C Mutations
    Machens, Andreas
    Lorenz, Kerstin
    Dralle, Henning
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (02): : E286 - E292
  • [42] In Silico Analysis of RET Variants in Medullary Thyroid Cancer: From the Computer to the Bedside
    Heineman, Thomas E.
    Joshi, Rohan
    Cohen, Marc A.
    Kuhel, William I.
    Kutler, David I.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2015, 152 (04) : 650 - 654
  • [43] RET mutation in medullary thyroid cancer promotes osteoblastic bone metastases in mice
    Bagheri-Yarmand, Rozita
    Martinez, Lucia
    Song, Jian H.
    Pagnotti, Gabriel M.
    Kuo, Truc T.
    Lin, Sue-Hwa
    Trivedi, Trupti
    Mohammad, Khalid S.
    Guise, Theresa A.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 : 325 - 325
  • [44] RET signals through focal adhesion kinase in medullary thyroid cancer cells
    Panta, GR
    Nwariaku, F
    Kim, LT
    SURGERY, 2004, 136 (06) : 1212 - 1216
  • [45] RET genotypes in sporadic medullary thyroid cancer:: studies in a large Italian series
    Fugazzola, Laura
    Muzza, Marina
    Mian, Caterina
    Cordella, Daniela
    Barollo, Susi
    Alberti, Luisella
    Cirello, Valentina
    Dazzi, Davide
    Girelli, Maria Elisa
    Opocher, Giuseppe
    Beck-Peccoz, Paolo
    Persani, Luca
    CLINICAL ENDOCRINOLOGY, 2008, 69 (03) : 418 - 425
  • [46] Role of RET in the pathogenesis of osteoblastic bone metastases due to medullary thyroid cancer
    Bagheri-Yarmand, Rozita
    Pagnotti, Gabriel M.
    Trivedi, Trupti
    Martinez, Lucia
    Martinez, Jade
    Kuo, Truc T.
    Guerra, Leah D.
    Song, Jian H.
    Lin, Sue Hwa
    Guise, Theresa A.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 206 - 207
  • [47] Inhibition of oncogenic RET signaling by Ad vector-mediated expression of a dominant-negative RET-mutant: implications for medullary thyroid cancer treatment
    Drosten, M
    Frilling, A
    Stiewe, T
    Putzer, BM
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S146 - S146
  • [48] Systemic and CNS Activity of Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET-Mutant Medullary Thyroid Cancer With Extensive CNS Metastases
    Andreev-Drakhlin, Alexander
    Cabanillas, Maria
    Amini, Behrang
    Subbiah, Vivek
    JCO PRECISION ONCOLOGY, 2020, 4 : 1302 - 1306
  • [49] Antiproliferative effects of Src inhibition on medullary thyroid cancer
    Liu, ZJ
    Falola, J
    Zhu, XD
    Gu, Y
    Kim, LT
    Sarosi, GA
    Anthony, T
    Nwariaku, FE
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (07): : 3503 - 3509
  • [50] Inhibition. of medullary thyroid carcinoma cell proliferation and RET phosphorylation by tyrosine kinase inhibitors
    Cohen, MS
    Hussain, HB
    Moley, JF
    SURGERY, 2002, 132 (06) : 960 - 966